The effects and consequences of selected club drugs.
Thomas E Freese, Karen Miotto, Cathy J Reback
Journal of Substance Abuse Treatment September 2002 DOI: 10.1016/s0740-5472(02)00267-2 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Key findings | The review characterizes MDMA, GHB, ketamine, and methamphetamine as club drugs whose popularity is increasing, notes their differing pharmacological classifications, and reports that medical visits for club drug-related toxicity have risen sharply across the country. |
Abstract
Ecstasy (MDMA), gamma-hydroxybutyrate (GHB), ketamine, and methamphetamine are 4 examples of club drugs that are increasing in popularity. Although the pharmacological classifications of these drugs vary, MDMA has structural similarities to both amphetamine and the hallucinogen mescaline. Ketamine and GHB are anesthetic agents and methamphetamine is a long-acting psychostimulant. Medical visits for club drug-related toxicity have sharply increased across the country. This article provides a brief review of the literature on club drugs.
Citations in the library
Cited by 9
- The Serotonin System and Spiritual Experiences American Journal of Psychiatry November 1, 2003
- Use and abuse of dissociative and psychedelic drugs in adolescence Pharmacology, Biochemistry, and Behavior January 27, 2021
- Ephenidine: A new psychoactive agent with ketamine-like NMDA receptor antagonist properties Neuropharmacology August 10, 2016
- Dissociative symptoms in generalized anxiety disorder and panic disorder and its relationship with temperament-character features Journal of Biotechnology and Strategic Health Research April 30, 2022
- Depersonalization and personality in panic disorder. Comprehensive Psychiatry 2011
and 4 more in the library
Cites 17
- Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings The Lancet October 1, 1998
- Attenuation of the Neuropsychiatric Effects of Ketamine With Lamotrigine Archives of General Psychiatry March 1, 2000
- 3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”): pharmacology and toxicology in animals and humans Addiction May 1, 1994
- (±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Studies in Animals Neuropsychobiology 2000
- Carrier‐Mediated Release of Serotonin by 3,4‐Methylenedioxymethamphetamine: Implications for Serotonin‐Dopamine Interactions Journal of Neurochemistry 1996
and 12 more in the library